Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
placebo gel-Watson Pharmaceuticals-overactive bladder
- Development stage
- Unknown
- Lead developer
- Allergan
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
This placebo gel is an inactive topical formulation developed by Watson Pharmaceuticals for use as a control in clinical trials evaluating oxybutynin chloride topical gel (Gelnique). It was specifically designed to match the physical properties, including appearance and application method, of the active oxybutynin gel to maintain the blinding of study participants and investigators. In clinical research, such as Phase 1 studies assessing gastric emptying via the acetaminophen absorption test, this placebo served as the negative comparator to isolate the pharmacological effects of the active antimuscarinic agent on bladder smooth muscle and other physiological processes.
- Other names
- Placebo Gel
Beyond the preview
Go deeper on placebo gel-Watson Pharmaceuticals-overactive bladder.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on placebo gel-Watson Pharmaceuticals-overactive bladder.